Net profit of Viyash Scientific declined 13.83% to Rs 38.44 crore in the quarter ended December 2025 as against Rs 44.61 crore during the previous quarter ended December 2024. Sales rose 10.90% to Rs 858.41 crore in the quarter ended December 2025 as against Rs 774.03 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales858.41774.03 11 OPM %20.4612.89 - PBDT172.8685.76 102 PBT114.3327.37 318 NP38.4444.61 -14 Powered by Capital Market - Live News

Sequent Scientific will hold a meeting of the Board of Directors of the Company on 5 February 2026.Powered by Capital Market - Live News

Net profit of Sequent Scientific rose 464.75% to Rs 14.74 crore in the quarter ended September 2025 as against Rs 2.61 crore during the previous quarter ended September 2024. Sales rose 15.01% to Rs 423.99 crore in the quarter ended September 2025 as against Rs 368.65 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales423.99368.65 15 OPM %13.1310.61 - PBDT44.3229.32 51 PBT28.8612.22 136 NP14.742.61 465 Powered by Capital Market - Live News

Sequent Scientific has allotted 11,86,700 equity shares under ESOP on 11 November 2025. Consequent to the allotment of the aforesaid equity shares, the issued and the paid-up equity share capital of the Company will increase from Rs. 50,35,25,296 consisting of 25,17,62,648 equity shares of Rs. 2 each to Rs. 50,58,98,696 consisting of 25,29,49,348 equity shares of Rs. 2 each.Powered by Capital Market - Live News

Sequent Scientific will hold a meeting of the Board of Directors of the Company on 14 November 2025.Powered by Capital Market - Live News